NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/11/2025
Back to search
Official data from USPTO
ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
ST13
US500000086271626Class
16, 41, 42, 44
Filing
86271626
Registration
4966469
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
12/30/2025
Trademark type
Word
Nice classes
16, 41, 42, 44
Filing date
05/05/2014
Registration date
05/24/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/11/2025
Last transaction
12/30/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2014-05-00
First use in commerce
2014-05-00
Drawing code
4
Owner type
03
Owner location
Hudson, FL
Examiner
MALASHEVICH, JASON
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M2GEN, CORP.
M. C. (pessoa física)
Representatives
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Technical classification
Nice Classes
Class 16Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Publicationsprinted materialsbrochurespamphletsbulletinsnewsletter and magazines in the field of cancerbioinformatics and biotechnologies
Class 41
Medical educational and training servicesconducting lecturesseminarsworkshopsconferencesinternshipsfellowshipsresidenciesworkshops in the field of cancer
Class 42
Medicalclinicalscientific research in the field of cancer; Application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; Scientific and technological servicescollaborative scientific research and development services for researchers in the fields of oncologydevelopment of proprietary bioinformatic analysis software pipelines and computer systems for collectingstoringcharacterizingsortingviewingdelivering medical data and research information to clients; designing genomic experiments in context of client driven strategic goals; providing scientific research dataincluding customproprietary bioinformatic analysis of data generated in the fields of genomics and oncology; data collection for research purposesdata mining and pattern recognitiondesigning clinical studiesgenerating genomic data from patient samples; Data collection for research purposesthe collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies; data collection for research purposesthe collection of mathematical and statistical dataclinical datapatient data and data of clinical studies relating to clinical response to cancer treatments; compiling data for research purposes in the field of medical sciencecompiling patient specific molecular and genomic datapatient specific clinical data and scientific clinical studies; scientific and technological servicesresearch services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of oncology; providing an online database comprised of medicalpharmaceuticalbiological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medicaltranslational medicineinterventional epidemiologybioinformaticsclinical information technologygenomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of bioinformatics and oncology; design and development of computer software for integration of patient specific datamolecular test resultsclinical studies and scientific results; providing online nondownloadable medical diagnostic and treatment research computer software for use by healthcare professionals; providing an online searchable database for clinical and scientific research in the field of oncology; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic datadrug protocolsclinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic datadrug protocolsclinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting servicesdesigning and conducting clinical studies and selecting patients for clinical studies in the field of cancer therapy for others; Conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research; technological and scientific data analysis in the field of oncology; scientific and research consulting servicestechnical data collectionresearch analysis and technical reporting of patients' outcomes and resulting prescribing data related thereto in the field of oncology; providing temporary use of non-downloadable scientific research and analysis software in the field of oncology and bioinformatics; Providing a website portal featuring bioinformatic research data and search engine for biomedical data for data mining and pattern recognitionselecting patients for clinical studiesdesigning clinical studiesgenerating genomic data from patient samples in the field of oncology; providing temporary use of non-downloadable bioinformatic software for diagnosing medical conditionspreparing medical dataresearch and reports for data mining and pattern recognitionselecting patient for clinical studiesdesigning clinical studiesgenerating genomic data from patient samples in the field of oncology; technical and scientific data analysis in the field of oncology
Class 44
Data collection for research purposesproviding medical evaluations of patients to determine acceptability for participation in clinical trials; Providing healthcare counselingscreeningdiagnosisprognosistreatmentrelapsepalliativeintegrative medicinesurvivorshipother related medical information in the field of cancer; Healthcare servicesproviding a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment researchadvising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions
Publications
History of USPTO decisions and trademark events.
55 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/11/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
08/29/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/24/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/10/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/10/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/08/2022
PUM1
OFFICE ACTION ISSUED POU1
05/25/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/25/2022
ES8R
TEAS SECTION 8 RECEIVED
05/10/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/24/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/29/2018
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/24/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/15/2016
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/08/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
04/08/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/08/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
04/08/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/08/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2016
ALIE
ASSIGNED TO LIE
03/18/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2016
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
09/16/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2015
GNRT
NON-FINAL ACTION E-MAILED
09/15/2015
CNRT
NON-FINAL ACTION WRITTEN
09/15/2015
IUAA
USE AMENDMENT ACCEPTED
09/15/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2015
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/11/2015
IUAF
USE AMENDMENT FILED
09/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/10/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/10/2015
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/10/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/11/2015
GNRT
NON-FINAL ACTION E-MAILED
03/11/2015
CNRT
NON-FINAL ACTION WRITTEN
03/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2014
GNRT
NON-FINAL ACTION E-MAILED
08/21/2014
CNRT
NON-FINAL ACTION WRITTEN
08/21/2014
DOCK
ASSIGNED TO EXAMINER
08/19/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/05/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/05/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/16/2014
NWAP
NEW APPLICATION ENTERED
05/08/2014
Continuous trademark protection
Get notified about every new filing that threatens ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.